These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 25819778)

  • 1. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys.
    Hajifathalian K; Ueda P; Lu Y; Woodward M; Ahmadvand A; Aguilar-Salinas CA; Azizi F; Cifkova R; Di Cesare M; Eriksen L; Farzadfar F; Ikeda N; Khalili D; Khang YH; Lanska V; León-Muñoz L; Magliano D; Msyamboza KP; Oh K; Rodríguez-Artalejo F; Rojas-Martinez R; Shaw JE; Stevens GA; Tolstrup J; Zhou B; Salomon JA; Ezzati M; Danaei G
    Lancet Diabetes Endocrinol; 2015 May; 3(5):339-55. PubMed ID: 25819778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys.
    Ueda P; Woodward M; Lu Y; Hajifathalian K; Al-Wotayan R; Aguilar-Salinas CA; Ahmadvand A; Azizi F; Bentham J; Cifkova R; Di Cesare M; Eriksen L; Farzadfar F; Ferguson TS; Ikeda N; Khalili D; Khang YH; Lanska V; León-Muñoz L; Magliano DJ; Margozzini P; Msyamboza KP; Mutungi G; Oh K; Oum S; Rodríguez-Artalejo F; Rojas-Martinez R; Valdivia G; Wilks R; Shaw JE; Stevens GA; Tolstrup JS; Zhou B; Salomon JA; Ezzati M; Danaei G
    Lancet Diabetes Endocrinol; 2017 Mar; 5(3):196-213. PubMed ID: 28126460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk prediction tools for populations in Asia.
    ; Barzi F; Patel A; Gu D; Sritara P; Lam TH; Rodgers A; Woodward M
    J Epidemiol Community Health; 2007 Feb; 61(2):115-21. PubMed ID: 17234869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions.
    WHO CVD Risk Chart Working Group
    Lancet Glob Health; 2019 Oct; 7(10):e1332-e1345. PubMed ID: 31488387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of 10-Year Risk of Death from Coronary Heart Disease, Stroke, and Cardiovascular Disease in a Pooled Analysis of Japanese Cohorts: EPOCH-JAPAN.
    Li Y; Yatsuya H; Tanaka S; Iso H; Okayama A; Tsuji I; Sakata K; Miyamoto Y; Ueshima H; Miura K; Murakami Y; Okamura T
    J Atheroscler Thromb; 2021 Aug; 28(8):816-825. PubMed ID: 33041313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study.
    Pylypchuk R; Wells S; Kerr A; Poppe K; Riddell T; Harwood M; Exeter D; Mehta S; Grey C; Wu BP; Metcalf P; Warren J; Harrison J; Marshall R; Jackson R
    Lancet; 2018 May; 391(10133):1897-1907. PubMed ID: 29735391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data.
    Zhu D; Chung HF; Dobson AJ; Pandeya N; Giles GG; Bruinsma F; Brunner EJ; Kuh D; Hardy R; Avis NE; Gold EB; Derby CA; Matthews KA; Cade JE; Greenwood DC; Demakakos P; Brown DE; Sievert LL; Anderson D; Hayashi K; Lee JS; Mizunuma H; Tillin T; Simonsen MK; Adami HO; Weiderpass E; Mishra GD
    Lancet Public Health; 2019 Nov; 4(11):e553-e564. PubMed ID: 31588031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study.
    Miller V; Mente A; Dehghan M; Rangarajan S; Zhang X; Swaminathan S; Dagenais G; Gupta R; Mohan V; Lear S; Bangdiwala SI; Schutte AE; Wentzel-Viljoen E; Avezum A; Altuntas Y; Yusoff K; Ismail N; Peer N; Chifamba J; Diaz R; Rahman O; Mohammadifard N; Lana F; Zatonska K; Wielgosz A; Yusufali A; Iqbal R; Lopez-Jaramillo P; Khatib R; Rosengren A; Kutty VR; Li W; Liu J; Liu X; Yin L; Teo K; Anand S; Yusuf S;
    Lancet; 2017 Nov; 390(10107):2037-2049. PubMed ID: 28864331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
    [No Abstract]   [Full Text] [Related]  

  • 10. Performance of cardiovascular disease risk prediction equations in more than 14 000 survivors of cancer in New Zealand primary care: a validation study.
    Tawfiq E; Selak V; Elwood JM; Pylypchuk R; Tin ST; Harwood M; Grey C; McKeage M; Wells S
    Lancet; 2023 Feb; 401(10374):357-365. PubMed ID: 36702148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of risk prediction equations to estimate survival in patients with colorectal cancer: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2017 Jun; 357():j2497. PubMed ID: 28620089
    [No Abstract]   [Full Text] [Related]  

  • 12. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults.
    Wu Y; Liu X; Li X; Li Y; Zhao L; Chen Z; Li Y; Rao X; Zhou B; Detrano R; Liu K; ;
    Circulation; 2006 Nov; 114(21):2217-25. PubMed ID: 17088464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment.
    Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration
    Lancet Diabetes Endocrinol; 2014 Aug; 2(8):634-47. PubMed ID: 24842598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Cardiovascular Disease Mortality in a Middle Eastern Country: Performance of the Globorisk and Score Functions in Four Population-Based Cohort Studies of Iran.
    Fahimfar N; Fotouhi A; Mansournia MA; Malekzadeh R; Sarrafzadegan N; Azizi F; Mansourian M; Sepanlou SG; Emamian MH; Hadaegh F; Roohafza H; Hashemi H; Poustchi H; Pourshams A; Samavat T; Sharafkhah M; Talaei M; Van Klaveren D; Steyerberg EW; Khalili D
    Int J Health Policy Manag; 2022 Feb; 11(2):210-217. PubMed ID: 32668896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of individual lifetime cardiovascular risk and potential treatment benefit: development and recalibration of the LIFE-CVD2 model to four European risk regions.
    Hageman SHJ; Kaptoge S; de Vries TI; Lu W; Kist JM; van Os HJA; Numans ME; Läll K; Bobak M; Pikhart H; Kubinova R; Malyutina S; Pająk A; Tamosiunas A; Erbel R; Stang A; Schmidt B; Schramm S; Bolton TR; Spackman S; Bakker SJL; Blaha M; Boer JMA; Bonnefond A; Brenner H; Brunner EJ; Cook NR; Davidson K; Dennison E; Donfrancesco C; Dörr M; Floyd JS; Ford I; Fu M; Gansevoort RT; Giampaoli S; Gillum RF; Gómez-de-la-Cámara A; Håheim LL; Hansson PO; Harms P; Humphries SE; Ikram MK; Jukema JW; Kavousi M; Kiechl S; Kucharska-Newton A; Pablos DL; Matsushita K; Meyer HE; Moons KGM; Mortensen MB; Muilwijk M; Nordestgaard BG; Packard C; Pamieri L; Panagiotakos D; Peters A; Potier L; Providencia R; Psaty BM; Ridker PM; Rodriguez B; Rosengren A; Sattar N; Schöttker B; Schwartz JE; Shea S; Shipley MJ; Sofat R; Thorand B; Verschuren WMM; Völzke H; Wareham NJ; Westbury L; Willeit P; Zhou B; Danesh J; Visseren FLJ; Di Angelantonio E; Pennells L; Dorresteijn JAN
    Eur J Prev Cardiol; 2024 Oct; 31(14):1690-1699. PubMed ID: 38752762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory-based and office-based Globorisk scores to predict 10-year risk of cardiovascular diseases among Iranians: results from the Fasa PERSIAN cohort.
    Jahangiry L; Dehghan A; Farjam M; Aune D; Rezaei F
    BMC Med Res Methodol; 2022 Nov; 22(1):305. PubMed ID: 36435774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2017 Nov; 359():j5019. PubMed ID: 29158232
    [No Abstract]   [Full Text] [Related]  

  • 18. [Application of the China-PAR risk prediction model for atherosclerotic cardiovascular disease in a rural northern Chinese population].
    Tang X; Zhang DD; He L; Cao Y; Wang JW; Li N; Huang SP; Dou HD; Gao P; Hu YH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2017 Jun; 49(3):439-445. PubMed ID: 28628144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials.
    Basu S; Sussman JB; Berkowitz SA; Hayward RA; Yudkin JS
    Lancet Diabetes Endocrinol; 2017 Oct; 5(10):788-798. PubMed ID: 28803840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study.
    Walli-Attaei M; Joseph P; Rosengren A; Chow CK; Rangarajan S; Lear SA; AlHabib KF; Davletov K; Dans A; Lanas F; Yeates K; Poirier P; Teo KK; Bahonar A; Camilo F; Chifamba J; Diaz R; Didkowska JA; Irazola V; Ismail R; Kaur M; Khatib R; Liu X; Mańczuk M; Miranda JJ; Oguz A; Perez-Mayorga M; Szuba A; Tsolekile LP; Prasad Varma R; Yusufali A; Yusuf R; Wei L; Anand SS; Yusuf S
    Lancet; 2020 Jul; 396(10244):97-109. PubMed ID: 32445693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.